Literature DB >> 12368329

Envelope proteins containing single amino acid substitutions support a structural model of the receptor-binding domain of bovine leukemia virus surface protein.

Elizabeth R Johnston1, Lorraine M Albritton, Kathryn Radke.   

Abstract

Functional domains of the strikingly conserved envelope (Env) glycoproteins of bovine leukemia virus (BLV) and its close relative, human T-cell leukemia virus type 1 (HTLV-1), are still being defined. We have used BLV Env protein variants to gain insights into the structure and function of this important determinant of viral infectivity. Each of 23 different single amino acid variants found in cDNA clones of env transcripts present after short-term culture of peripheral blood mononuclear cells from BLV-infected sheep was expressed in COS-1 cells and tested for the ability to mediate cell fusion and to be cleaved to surface (SU) and transmembrane (TM) protein subunits. Of 11 Env variants that failed to induce syncytia or did so poorly, 7 contained changes in amino acids identical or chemically conserved in the HTLV-1 Env protein. These seven included the four variants that showed aberrant proteolytic cleavage and poor cell surface expression, underscoring their importance for Env structure. Ten of 12 variants that retained wild-type syncytium-inducing ability clustered in the N-terminal half of BLV SU, which forms the putative receptor-binding domain (RBD). Several variants in the RBD showed evidence of subtle misfolding, as judged by reduced binding to monoclonal antibodies recognizing conformational epitopes F, G, and H formed by the N terminus of SU. We modeled the BLV RBD by aligning putative structural elements with known elements of the ecotropic Friend murine leukemia virus RBD monomer. All the variant RBD residues but one are exposed on the surface of this BLV model. These variants as well as function-altering, antibody-reactive residues defined by other investigators group on one face of the molecular model. They are strikingly absent from the opposite face, implying that it is likely to face inward in Env complexes. This surface might interact with the C-terminal domain of SU or with an adjacent monomer in the Env oligomer. This location suggests an orientation for the monomer of ecotropic Friend murine leukemia virus RBD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368329      PMCID: PMC136609          DOI: 10.1128/jvi.76.21.10861-10872.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins.

Authors:  B Kobe; R J Center; B E Kemp; P Poumbourios
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

2.  Conservative mutations in the immunosuppressive region of the bovine leukemia virus transmembrane protein affect fusion but not infectivity in vivo.

Authors:  J S Gatot; I Callebaut; J P Mornon; D Portetelle; A Burny; P Kerkhofs; R Kettmann; L Willems
Journal:  J Biol Chem       Date:  1998-05-22       Impact factor: 5.157

3.  Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 angstrom resolution.

Authors:  D Fass; R A Davey; C A Hamson; P S Kim; J M Cunningham; J M Berger
Journal:  Science       Date:  1997-09-12       Impact factor: 47.728

4.  Envelope gene sequence of HTLV-1 isolate MT-2 and its comparison with other HTLV-1 isolates.

Authors:  G S Gray; M White; T Bartman; D Mann
Journal:  Virology       Date:  1990-07       Impact factor: 3.616

5.  The SU and TM envelope protein subunits of bovine leukemia virus are linked by disulfide bonds, both in cells and in virions.

Authors:  E R Johnston; K Radke
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

6.  Topographical analysis by monoclonal antibodies of BLV-gp51 epitopes involved in viral functions.

Authors:  C Bruck; D Portetelle; A Burny; J Zavada
Journal:  Virology       Date:  1982-10-30       Impact factor: 3.616

7.  Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.

Authors:  I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

8.  Identification of functional regions in the human T-cell leukemia virus type I SU glycoprotein.

Authors:  L Delamarre; C Pique; D Pham; T Tursz; M C Dokhélar
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

Review 9.  Folding and assembly of viral membrane proteins.

Authors:  R W Doms; R A Lamb; J K Rose; A Helenius
Journal:  Virology       Date:  1993-04       Impact factor: 3.616

10.  Monoclonal antibodies define eight independent antigenic regions on the bovine leukemia virus (BLV) envelope glycoprotein gp51.

Authors:  C Bruck; S Mathot; D Portetelle; C Berte; J D Franssen; P Herion; A Burny
Journal:  Virology       Date:  1982-10-30       Impact factor: 3.616

View more
  20 in total

1.  Design and Synthesis of Bovine Leukemia Virus-Associated Peptide-Based Qβ Conjugate Eliciting Long-Lasting Neutralizing Antibodies in Mice.

Authors:  Shivangi Chugh; Cheryl Swenson; Vilma Yuzbasiyan-Gurkan; Xuefei Huang
Journal:  ACS Infect Dis       Date:  2022-04-28       Impact factor: 5.578

2.  Identification of the receptor binding domain of the mouse mammary tumor virus envelope protein.

Authors:  Yuanming Zhang; John C Rassa; Maria Elena deObaldia; Lorraine M Albritton; Susan R Ross
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

3.  Dileucine and YXXL motifs in the cytoplasmic tail of the bovine leukemia virus transmembrane envelope protein affect protein expression on the cell surface.

Authors:  Sinisa Novakovic; Earl T Sawai; Kathryn Radke
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

4.  The receptor complex associated with human T-cell lymphotropic virus type 3 (HTLV-3) Env-mediated binding and entry is distinct from, but overlaps with, the receptor complexes of HTLV-1 and HTLV-2.

Authors:  Kathryn S Jones; Ying K Huang; Sébastien A Chevalier; Philippe V Afonso; Cari Petrow-Sadowski; Daniel C Bertolette; Antoine Gessain; Francis W Ruscetti; Renaud Mahieux
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

Review 5.  Molecular aspects of HTLV-1 entry: functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors.

Authors:  Kathryn S Jones; Sophie Lambert; Manuella Bouttier; Laurence Bénit; Frank W Ruscetti; Olivier Hermine; Claudine Pique
Journal:  Viruses       Date:  2011-06-15       Impact factor: 5.048

6.  Identification of the hASCT2-binding domain of the Env ERVWE1/syncytin-1 fusogenic glycoprotein.

Authors:  Valérie Cheynet; Guy Oriol; François Mallet
Journal:  Retrovirology       Date:  2006-07-04       Impact factor: 4.602

7.  Sequencing and phylogenetic analysis of the gp51 gene from Korean bovine leukemia virus isolates.

Authors:  EunJung Lee; Eun-Ju Kim; Ha-Kyung Joung; Bo-Hye Kim; Jae-Young Song; In-Soo Cho; Kyoung-Ki Lee; Yeun-Kyung Shin
Journal:  Virol J       Date:  2015-04-15       Impact factor: 4.099

8.  The molecular characterization of bovine leukaemia virus isolates from Eastern Europe and Siberia and its impact on phylogeny.

Authors:  Marzena Rola-Łuszczak; Aneta Pluta; Monika Olech; Irina Donnik; Maxim Petropavlovskiy; Anton Gerilovych; Irina Vinogradova; Bhudipa Choudhury; Jacek Kuźmak
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

9.  Highly specific inhibition of leukaemia virus membrane fusion by interaction of peptide antagonists with a conserved region of the coiled coil of envelope.

Authors:  Daniel Lamb; Alexander W Schüttelkopf; Daan M F van Aalten; David W Brighty
Journal:  Retrovirology       Date:  2008-08-04       Impact factor: 4.602

Review 10.  Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human.

Authors:  Nicolas Gillet; Arnaud Florins; Mathieu Boxus; Catherine Burteau; Annamaria Nigro; Fabian Vandermeers; Hervé Balon; Amel-Baya Bouzar; Julien Defoiche; Arsène Burny; Michal Reichert; Richard Kettmann; Luc Willems
Journal:  Retrovirology       Date:  2007-03-16       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.